February 25, 2023
7:00AM - 4:00PM EST

Physician Program

OOS Annual Meeting

View Physician Agenda > 

Registration for this event is now closed.  Please contact the Ohio Ophthalmological Society for registrations at: (614) 527-6799.


  • Discuss the prevalence and impact of retina disease, glaucoma, and other external diseases;
  • Review current literature and discuss new and emerging data aimed at improving the management of patients;
  • Incorporate best available evidence and recent clinical research to improve patient assessment and treatment approaches; and,
  • Apply quality and risk management strategies to address critical business issues in the ophthalmology practice.

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ohio State Medical Association (OSMA) and the Ohio Ophthalmological Society. The OSMA is accredited by the ACCME to provide continuing medical education for physicians.

The OSMA designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Successful completion of this CME activity, which includes participation in the evaluation component, earns credit towards the Lifelong Learning requirement for the American Board of Ophthalmology’s Continuing Certification program. The OSMA, as the CME provider, will submit learner completion information to the ACCME for the purpose of granting credit.

Cancellations made on or before 4 pm on Thursday, Feb. 16 will receive a full refund. If made Friday, Feb. 17 or after, you will receive a refund less a $100 processing fee, or you can have the full registration applied to your 2024 registration. There will be no refunds for anyone who does not cancel in advance and/or doesn't show the day of the meeting. If the OOS cancels for any reason, 100% registration refunds will be made. Substitutions can be made at no charge.


Alcon Vision
Alexion AstraZeneca
Allergan, an AbbVie Company
Apellis Pharmaceuticals
Association of Technical Personnel
Bausch + Lomb
BioTissue Ocular
CVP Physicians & EyeCare Partners
Dompe Pharmaceuticals
Heidelberg Engineering
Horizon Therapeutics
Icare USA, Inc
Johnson and Johnson Vision
Lions Eye Bank of West Central Ohio
Mallinckrodt Pharmaceuticals
Modernizing Medicine
New World Medical
Notal Vision
Ocular Therapeutix
Optos Inc.
Premier Ophthalmic Services
Rayner Surgical
Regeneron Pharmaceuticals Inc.
RxSight, Inc.
Scope Eyecare & Healthcare
Topcon Healthcare
Travere Therapeutics
Westmoreland Pharmacy


Printer-Friendly Version